195 related articles for article (PubMed ID: 19017176)
1. Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.
Smedby KE; Askling J; Mariette X; Baecklund E
J Intern Med; 2008 Dec; 264(6):514-27. PubMed ID: 19017176
[TBL] [Abstract][Full Text] [Related]
2. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
Smedby KE; Baecklund E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?
Baecklund E; Smedby KE; Sutton LA; Askling J; Rosenquist R
Semin Cancer Biol; 2014 Feb; 24():61-70. PubMed ID: 24333759
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?
Yadlapati S; Efthimiou P
Biomed Res Int; 2016; 2016():8631061. PubMed ID: 27429984
[TBL] [Abstract][Full Text] [Related]
5. Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: a cancer registry-based analysis in the south of the Netherlands.
van de Schans SA; van Spronsen DJ; Hooijkaas H; Janssen-Heijnen ML; Coebergh JW
Autoimmun Rev; 2011 Feb; 10(4):228-34. PubMed ID: 21074639
[TBL] [Abstract][Full Text] [Related]
6. B-cell lymphoproliferation in chronic inflammatory rheumatic diseases.
Hansen A; Lipsky PE; Dörner T
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):561-9. PubMed ID: 17906611
[TBL] [Abstract][Full Text] [Related]
7. Introduction: The role of inflammation, autoimmune disease and infectious agents in development of leukaemia and lymphoma.
Rosenquist R
J Intern Med; 2008 Dec; 264(6):512-3. PubMed ID: 19017175
[No Abstract] [Full Text] [Related]
8. [Lymphoproliferative disease in patients with autoimmune and inflammatory diseases: significance of antigenic stimulation and inflammatory processes].
Tvarůzková Z; Pavlová S; Doubek M; Mayer J; Pospísilová S
Cas Lek Cesk; 2011; 150(3):161-8. PubMed ID: 21560455
[TBL] [Abstract][Full Text] [Related]
9. The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications.
Fisher SG; Fisher RI
Curr Opin Oncol; 2006 Sep; 18(5):417-24. PubMed ID: 16894287
[TBL] [Abstract][Full Text] [Related]
10. Adjuvants and lymphoma risk as part of the ASIA spectrum.
Butnaru D; Shoenfeld Y
Immunol Res; 2015 Feb; 61(1-2):79-89. PubMed ID: 25582758
[TBL] [Abstract][Full Text] [Related]
11. Autoimmunity and lymphomagenesis.
Goldin LR; Landgren O
Int J Cancer; 2009 Apr; 124(7):1497-502. PubMed ID: 19089924
[TBL] [Abstract][Full Text] [Related]
12. Development of autoimmunity in lymphoma.
Jardin F
Expert Rev Clin Immunol; 2008 Mar; 4(2):247-66. PubMed ID: 20477054
[TBL] [Abstract][Full Text] [Related]
13. The aetiology of B-cell lymphoid malignancies with a focus on chronic inflammation and infections.
Smedby KE; Ponzoni M
J Intern Med; 2017 Nov; 282(5):360-370. PubMed ID: 28875507
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory cells and immune microenvironment in malignant lymphoma.
de Jong D; Enblad G
J Intern Med; 2008 Dec; 264(6):528-36. PubMed ID: 19017177
[TBL] [Abstract][Full Text] [Related]
15. The target tissue in autoimmunity--an influential niche.
Hill NJ; Hultcrantz M; Sarvetnick N; Flodström-Tullberg M
Eur J Immunol; 2007 Mar; 37(3):589-97. PubMed ID: 17301949
[TBL] [Abstract][Full Text] [Related]
16. The role of cytokines in the regulation of ocular autoimmune inflammation.
Vallochi AL; Commodaro AG; Schwartzman JP; Belfort R; Rizzo LV
Cytokine Growth Factor Rev; 2007; 18(1-2):135-41. PubMed ID: 17349814
[TBL] [Abstract][Full Text] [Related]
17. [Inflammation and auto-immunity: an update on the NOD-like receptors and their clinical role].
Gaide O
Rev Med Suisse; 2008 Apr; 4(155):1103-6. PubMed ID: 18610723
[TBL] [Abstract][Full Text] [Related]
18. Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms.
Khanmohammadi S; Shabani M; Tabary M; Rayzan E; Rezaei N
Crit Rev Oncol Hematol; 2020 Jun; 150():102945. PubMed ID: 32353704
[TBL] [Abstract][Full Text] [Related]
19. [Autoimmune and inflammatory mechanisms of atherosclerosis development].
Nagornev VA; Mal'tseva SV
Arkh Patol; 2005; 67(5):6-15. PubMed ID: 16323472
[TBL] [Abstract][Full Text] [Related]
20. Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy.
Illes A; Varoczy L; Papp G; Wilson PC; Alex P; Jonsson R; Kovacs T; Konttinen YT; Zeher M; Nakken B; Szodoray P
Scand J Immunol; 2009 May; 69(5):387-400. PubMed ID: 19508370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
